Counterfeit Drug Detection Device Market Dynamic Innovation in Technology, Global Future Demand & Business Strategy 2029
Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmaceutical product that is deliberately mislabeled with respect to identity and/or source. Counterfeit drugs may include branded and generic products, drugs with the correct ingredients or with the wrong ingredients; without active pharmaceutical ingredient (API), with insufficient active pharmaceutical ingredients (API) or with fake packaging (WHO 2012).
According to World Health Organization (WHO), counterfeit drugs are estimated around 10% of all pharmaceuticals. North America is the largest economy and largest pharmaceutical market in the world and in spite of strict regulatory policies; maximum drugs that market online are counterfeit. As per estimation from WHO in 2012, the loss suffered by pharmaceutical industry for counterfeit drugs were over $75 Bn.
Counterfeit Drug Detection Market: Drivers and Restraints
With increasing incidence of counterfeit drugs in the world the demand for counterfeit drug detection devices are also increasing. According to Pharmaceutical Security Institute, the number of counterfeit drugs incident has increased from 2,193 in 2013 to 3,509 in 2017. Out of these 3,509 incidents, 1,677 are reported in North America. Medications in the anti-infectives, genito-urinary, and central nervous system (CNS) therapeutic categories were mostly counterfeit.
Request For Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7838
Counterfeit drug detection devices have advanced enormously from large laboratory set-up to battery operated handheld gadgets. The ease of use, increased efficiency, on-field result and rapid test result are the major factors fuelling the growth of the concerned market. Several government initiatives to combat the counterfeit drug can also a major reason behind the growth of Counterfeit drug detection devices. For example, U.S. FDA has introduced a counterfeit drug detection device for the identification of counterfeit drug and package, the latest version of this counterfeit drug detection device CD-3 is costs around US$ 1,000.
Policy implementation for unit level track-and-trace is another factor fueling the growth of the market. Increased efforts to combat counterfeit drugs by governments and private companies. German customs have started a project called “Blue Project” which enables government to identify illegal online drug-trading sites and the tracing of financial transactions.
Although lack of awareness about the counterfeit drugs can hamper the growth of counterfeit drug detection device market. People are not aware about the technological advancements in counterfeit drug detection device which impending the adoption of new technology handheld devices of counterfeit drug detection devices and can restrain the growth of counterfeit drug detection device market.
The devices are costly. High cost of counterfeit drug detection device set-up can restrict the growth of counterfeit drug detection device market.
Counterfeit Drug Detection Device Market: Segmentation
To gain a comprehensive and a better understanding of the future market equity, the Counterfeit Drug Detection Device market report is segmented based on technology, application, end user and region.
Based on the technology type Counterfeit Drug Detection Device is segmented into:
- Infrared and Near Infrared Spectroscopy
- Raman Spectroscopy
- Rapid Chemical Testing
- X-ray diffraction (XRD) and X-ray fluorescence (XRF) Spectroscopy
- RFID Technology
- Scanning and Imaging Systems
- Other Packaging and Labelling Counterfeit Drug Detection Device
Based on application Counterfeit Drug Detection Device Market can be segmented into:
- Counterfeit Drug Detection Device for Chemical Composition
- Counterfeit Drug Detection Device for Packaging & Labelling Detection
Based on end user, Counterfeit Drug Detection Device Market can be segmented into:
- Pharmaceutical companies
- Drug testing laboratories
- Research organizations
On the basis of geography, Counterfeit Drug Detection Device can be segmented as:
- North- America
- Eastern Europe
- Western Europe
- Asia-Pacific excluding China & Japan
- Middle East and Africa
- Latin America
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the Scoliosis Management market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
- Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org